Cyfra 21-1 (Cytokeratin 19 Fragment)

Clinical Significance

   Cyfra 21-1 as a biologic marker of non-small cell lung cancer. It also reflects the extent of the disease and has an independent prognostic role along with performance status and disease stage in NSCLC.

Specimen

   Serum

Stability

   Refrigerated (preferred) : 2 weeks

   Frozen : 2 months

   Ambient : 48 hours

Reference Range

   ≤ 3.3 ng/ml

Interpretation

   Elevated levels of serum CYFRA 21-1 indicate the presence of squamous cell components.

Limitation

   Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.